Conflicting data on the protein expression of MSH2 in prostate cancer exist; while some studies have suggested a link between loss of MSH2 expression and aggressive prostate cancer features [42,43], others have associated overexpression of MSH2 with prostate cancer progression and poor patient prognosis [44,45,46]. The gene discussed is MSH2; the disease is prostate carcinoma.